Cargando…
TYPE I INTERFERON-MEDIATED NEUROINFLAMMATORY PROGRAM AND SYNAPSE LOSS IN ALZHEIMER’S DISEASE
The cytokine family type I interferon (IFN) is a major innate immune mediator extensively studied in the peripheral immune responses but largely under-investigated in AD. Previously, we established that innate immune cells readily produce IFN in response to amyloid fibrils containing nucleic acids a...
Autores principales: | Roy, Ethan, Wang, Baiping, Zheng, Hui, Cao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6846830/ http://dx.doi.org/10.1093/geroni/igz038.349 |
Ejemplares similares
-
MTOR-DRIVEN ALTERATIONS IN THE BRAIN MICROVASCULAR PROTEOME IN ALZHEIMER’S DISEASE
por: Banh, Andy, et al.
Publicado: (2019) -
NEW APPROACH TO STUDYING COLLECTIVE EFFECTS OF GENETIC FACTORS ON ALZHEIMER’S DISEASE
por: Yashin, Anatoliy, et al.
Publicado: (2019) -
IMPROVING BRAIN AGE PREDICTION MODELS: INCORPORATION OF AMYLOID STATUS IN ALZHEIMER’S DISEASE
por: Ly, Maria, et al.
Publicado: (2019) -
COMBINING MACHINE LEARNING WITH AUTOMATED NEMATODE LIFESPAN ANALYSIS TO IDENTIFY MODIFIERS OF ALZHEIMER’S DISEASE
por: Russell, Joshua, et al.
Publicado: (2019) -
TAU-INDUCED ASTROCYTE SENESCENCE: A NOVEL MECHANISM FOR NEURONAL DYSFUNCTION IN ALZHEIMER’S DISEASE
por: Olson, Angela, et al.
Publicado: (2019)